BioQ Pharma to Present at the 27th Annual Oppenheimer Healthcare Conference

Mar 17, 2017
SAN FRANCISCO, Mar. 17, 2017: BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the 27th Annual Oppenheimer Healthcare Conference to be held in New York City on March 21st and 22nd, 2017.

Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, March 22nd at 2:45 p.m. Eastern Daylight Time.



About BioQ Pharma

BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, Galen Limited, and West Pharmaceutical Services.  

BioQ Pharma Contact Information:

Josh Kriesel
President and CEO
415-336-6496

Ron Pauli
Chief Financial Officer
415-889-7707

Walter Cleymans
Vice President Europe
Phone: +32 474 (053) 253

Media:
Stephanie Carrington
Integrated Corporate Relations, Inc (ICR)
stephanie.carrington@icrinc.com